Komipharm International Co., Ltd.
API veterinari e iniettabili finiti per suini e pollame, esportati in 70 paesi.
Komipharm produce prodotti farmaceutici veterinari tra cui iniettabili e polveri solubili di amoxicillina, florfenicolo e tilmicosina. Lo stabilimento certificato GMP rifornisce distributori di prodotti per la salute animale e grandi integratori in America Latina e nel Sud-Est asiatico.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Siheung, South Korea
- Website
- komipharm.com
- Categories
- Prodotti veterinari e salute animale
- Markets
- Brasile, Vietnam, Indonesia, Filippine
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-09 Domain registry record
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)